238 related articles for article (PubMed ID: 27082983)
1. The Human Glycoprotein Salivary Agglutinin Inhibits the Interaction of DC-SIGN and Langerin with Oral Micro-Organisms.
Boks MA; Gunput ST; Kosten I; Gibbs S; van Vliet SJ; Ligtenberg AJ; van Kooyk Y
J Innate Immun; 2016; 8(4):350-61. PubMed ID: 27082983
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
Holla A; Skerra A
Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
[TBL] [Abstract][Full Text] [Related]
3. Human Herpesvirus 8 Infects and Replicates in Langerhans Cells and Interstitial Dermal Dendritic Cells and Impairs Their Function.
Rappocciolo G; Jais M; Piazza PA; DeLucia DC; Jenkins FJ; Rinaldo CR
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768873
[TBL] [Abstract][Full Text] [Related]
4. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
[TBL] [Abstract][Full Text] [Related]
5. Rational-Differential Design of Highly Specific Glycomimetic Ligands: Targeting DC-SIGN and Excluding Langerin Recognition.
Porkolab V; Chabrol E; Varga N; Ordanini S; Sutkevičiu Tė I; Thépaut M; García-Jiménez MJ; Girard E; Nieto PM; Bernardi A; Fieschi F
ACS Chem Biol; 2018 Mar; 13(3):600-608. PubMed ID: 29272097
[TBL] [Abstract][Full Text] [Related]
6. Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.
Varga N; Sutkeviciute I; Guzzi C; McGeagh J; Petit-Haertlein I; Gugliotta S; Weiser J; Angulo J; Fieschi F; Bernardi A
Chemistry; 2013 Apr; 19(15):4786-97. PubMed ID: 23417900
[TBL] [Abstract][Full Text] [Related]
7. DCIR interacts with ligands from both endogenous and pathogenic origin.
Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
[TBL] [Abstract][Full Text] [Related]
8. Host Langerin (CD207) is a receptor for Yersinia pestis phagocytosis and promotes dissemination.
Yang K; Park CG; Cheong C; Bulgheresi S; Zhang S; Zhang P; He Y; Jiang L; Huang H; Ding H; Wu Y; Wang S; Zhang L; Li A; Xia L; Bartra SS; Plano GV; Skurnik M; Klena JD; Chen T
Immunol Cell Biol; 2015 Oct; 93(9):815-24. PubMed ID: 25829141
[TBL] [Abstract][Full Text] [Related]
9. Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets.
Duinkerken S; Horrevorts SK; Kalay H; Ambrosini M; Rutte L; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y
Theranostics; 2019; 9(20):5797-5809. PubMed ID: 31534520
[TBL] [Abstract][Full Text] [Related]
10. Receptor usage dictates HIV-1 restriction by human TRIM5α in dendritic cell subsets.
Ribeiro CM; Sarrami-Forooshani R; Setiawan LC; Zijlstra-Willems EM; van Hamme JL; Tigchelaar W; van der Wel NN; Kootstra NA; Gringhuis SI; Geijtenbeek TB
Nature; 2016 Dec; 540(7633):448-452. PubMed ID: 27919079
[TBL] [Abstract][Full Text] [Related]
11. Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin.
Andreini M; Doknic D; Sutkeviciute I; Reina JJ; Duan J; Chabrol E; Thepaut M; Moroni E; Doro F; Belvisi L; Weiser J; Rojo J; Fieschi F; Bernardi A
Org Biomol Chem; 2011 Aug; 9(16):5778-86. PubMed ID: 21735039
[TBL] [Abstract][Full Text] [Related]
12. Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1.
van den Berg LM; Cardinaud S; van der Aar AM; Sprokholt JK; de Jong MA; Zijlstra-Willems EM; Moris A; Geijtenbeek TB
J Immunol; 2015 Aug; 195(4):1763-73. PubMed ID: 26170391
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin interactions are required for Langerhans cell differentiation.
Mayumi N; Watanabe E; Norose Y; Watari E; Kawana S; Geijtenbeek TB; Takahashi H
Eur J Immunol; 2013 Jan; 43(1):270-80. PubMed ID: 23135957
[TBL] [Abstract][Full Text] [Related]
14. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.
de Witte L; Nabatov A; Pion M; Fluitsma D; de Jong MA; de Gruijl T; Piguet V; van Kooyk Y; Geijtenbeek TB
Nat Med; 2007 Mar; 13(3):367-71. PubMed ID: 17334373
[TBL] [Abstract][Full Text] [Related]
15. Langerin functions as an antiviral receptor on Langerhans cells.
van der Vlist M; Geijtenbeek TB
Immunol Cell Biol; 2010; 88(4):410-5. PubMed ID: 20309013
[TBL] [Abstract][Full Text] [Related]
16. High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin.
Galustian C; Park CG; Chai W; Kiso M; Bruening SA; Kang YS; Steinman RM; Feizi T
Int Immunol; 2004 Jun; 16(6):853-66. PubMed ID: 15136555
[TBL] [Abstract][Full Text] [Related]
17. C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi.
de Jong MA; Vriend LE; Theelen B; Taylor ME; Fluitsma D; Boekhout T; Geijtenbeek TB
Mol Immunol; 2010 Mar; 47(6):1216-25. PubMed ID: 20097424
[TBL] [Abstract][Full Text] [Related]
18. Abundant and superficial expression of C-type lectin receptors in ectocervix of women at risk of HIV infection.
Hirbod T; Kaldensjö T; Lopalco L; Klareskog E; Andersson S; Uberti-Foppa C; Ferrari D; Manghi M; Andersson J; Loré K; Broliden K
J Acquir Immune Defic Syndr; 2009 Jul; 51(3):239-47. PubMed ID: 19363450
[TBL] [Abstract][Full Text] [Related]
19. The bacteria binding glycoprotein salivary agglutinin (SAG/gp340) activates complement via the lectin pathway.
Leito JT; Ligtenberg AJ; van Houdt M; van den Berg TK; Wouters D
Mol Immunol; 2011 Oct; 49(1-2):185-90. PubMed ID: 21920605
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells.
Appelmelk BJ; van Die I; van Vliet SJ; Vandenbroucke-Grauls CM; Geijtenbeek TB; van Kooyk Y
J Immunol; 2003 Feb; 170(4):1635-9. PubMed ID: 12574325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
